Overview

Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer

Status:
Completed
Trial end date:
1988-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of continuous use of TTS fentanyl (a transdermal patch delivering the narcotic pain reliever fentanyl) for the treatment of chronic cancer pain.
Phase:
Phase 3
Details
Lead Sponsor:
Alza Corporation, DE, USA
Treatments:
Fentanyl